ArticleScientific reports2025
Prediction of longitudinal outcomes and novel cluster identification in epilepsy.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The longitudinal course of epilepsy remains largely unpredictable. This study aimed to predict final outcome and classify dynamic longitudinal trajectories using artificial intelligence. A total of 2586 patients who first visited our epilepsy specialists between 2008 and 2017 and with at least 3 years of follow-up, were retrospectively enrolled. Supervised and unsupervised learning algorithms were employed to identify clusters with distinct longitudinal courses and to examine epilepsy parameters within each cluster. XGBoost showed slightly higher performance than the others for the final outcome prediction. We identified three clusters associated with final seizure freedom and two clusters with persistent seizures. The first cluster demonstrated early remission, often linked to infectious or immune etiologies. Two additional clusters with final seizure freedom exhibited delayed remission. One of these clusters, characterized by relatively lower initial seizure frequency, showed generalized irregular slowing on EEG, and cerebromalacia. The other cluster, with an intermediate seizure frequency, displayed features commonly associated with generalized epilepsy. The fourth cluster displayed ongoing seizures with reduced frequency compared to baseline, with focal spike-and-wave, irregular slowing on EEG, and epilepsy-associated tumor. The fifth cluster experienced consistently high seizure frequency from onset, characterized by hippocampal sclerosis, male predominance, and longer epilepsy duration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.